The European Commission has opened an antitrust investigation into whether the Swiss drug company Vifor Pharma restricted competition […]

The MS Society responds as MS therapy Fampyra is rejected

Updated Date: Tue, 14 Jun 2022 00:00:00 EDT

COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, researchers find after showing rebound patient did […]

European countries could significantly reduce the health harms caused by alcohol consumption by introducing minimum pricing for alcoholic […]

Eplontersen significantly improved patient-reported quality of life following successful research

Oliver highlights several important matters relating to access to rehabilitation services.1 As he points out, there can be […]

Smoking may increase the risk of developing schizophrenia by between 53% and 127% and of developing depression by […]

Pre-clinical screening technology could increase cancer test numbers by 50 times

Based on a pilot clinical trial, close to 97% of dose recommendations by CURATE.AI were accepted by clinicians; […]